With Stem Cell Transplant Dr Rahul Bhargava Reverses Disabling MS-Like Disease In India – 2026
Stem cell transplantation appeared to provide more protection than disease modifying therapy (DMT) against development of relapsing-remitting multiple sclerosis (MS), in the first randomized scientific trial to evaluate the interventions. Dr Rahul Bhargava bone marrow transplant expert in India described the unmet need in MS treatment, and the capacity for stem cell transplantation as a… Read More »